ISSUE: Patient-reported performance measures (PR-PMs) of experience and outcomes are cited as key ways to bring the patient voice into accountable care models; however, current oncology PR-PMs may not be sufficient to assess factors most meaningful to cancer patients and their providers. As more measures are developed, questions arise around the value of using patient-reported measures (PRMs) in value-based payment (VBP) programs, priorities for measure development and implementation, and accountability across stakeholders. Stakeholders have distinct perspectives on these controversies that should be explored when considering PR-PMs for VBP.

OVERVIEW: Despite the importance of including the patient voice in quality measurement, difficulty developing methodologically-sound patient-reported measures (PRMs) and implementing meaningful patient-reported performance measures (PR-PMs) has contributed to gaps in the availability and use of PR-PMs for accountability programs. A recent National Pharmaceutical Council (NPC) and Discern Health research project examined the current state of patient-reported measurement in oncology and charted a path for filling gaps. Building on project findings, this panel will debate the controversies around using PRMs in accountability programs. Kimberly Westrich will moderate the panel, provide an overview of the current state of PRMs in oncology, and pose questions for the panelists to debate: What are the risks and barriers to implementing PR-PMs in value-based payment? What are the top priorities for measure development? How should patients and caregivers be involved in development? Who should be responsible for funding development and implementation efforts? Debate time will be divided evenly between the presenters, with at least ten minutes for audience discussion. For each topic, Yousuf Zafar, Garth Callaghan, and Cynthia Grossman will offer provider, patient, and research perspectives. This multi-stakeholder discussion is aimed at providing insight on the role of PR-PMs in value-based payment and identifying key opportunities for future efforts in quality measurement and measure implementation.